NSE: ZYDUSWELL | BSE: 531335

Mid-range Performer

Download real time

2030.70 35.90 (1.80%)

High vol. this week

NSE 25 Jun, 2025 1:57 PM (IST)

12,921.8

Market Cap

High in industry

0.5

Beta 1Year

Very Low volatility

Dividend

Zydus Wellness Ltd. has an upcoming dividend of ₹6.00 per share due on 11 Jul 2025 See details

Zydus Wellness Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for ZYDUSWELL, BSE:531335 Zydus Wellness Ltd.

Search Inside the pdf :

Zydus Wellness Ltd.

21 May 2025

2030.70

1.80%

BP Equities Q4FY25 Result Update Zydus Wellness Ltd

Results Update: Zydus Wellness Ltd.

BP Wealth

Zydus Wellness Ltd. average weekly volume is high.

Zydus Wellness Ltd.

13 Feb 2025

2030.70

1.80%

Zydus Wellness Limited’s (ZWL’s) Q3FY25 numbers were mixed with revenue beating estimates and growing by 14.6% y-o-y to Rs. 462 crore (versus expectation of Rs. 435 crore), while OPM stood flat y-o-y at 3.1% and missed expectations of 5.8%. Volume growth stood at 4.8%.

Zydus Wellness Ltd. average weekly volume is high.

Zydus Wellness Ltd.

05 Feb 2025

2030.70

1.80%

Zydus Wellness (HOLD): Margin focus over reinvestments

Hold: Zydus Wellness Ltd.

Target

BOB Capital Markets Ltd.

Q3FY25 sales came in 2% above consensus while EBITDA was 2% lower due to 15bps lower-than-expected margins

Zydus Wellness Ltd. has gained 20.86% in the last 3 Months

Zydus Wellness Ltd.

11 Nov 2024

2030.70

1.80%

Mixed bag Q2

Buy: Zydus Wellness Ltd.

Target

Sharekhan

Zydus Wellness Limited’s (ZWL’s) Q2FY2025 numbers were mixed with revenue growing by 12% y-o-y to Rs. 493 crore (versus Rs. 475 crore expected), while OPM stood flat y-o-y at 4% (against expectation of 5.3%). Adjusted PAT came in at Rs. 16 crore.

Zydus Wellness Ltd. average weekly volume is high.

Zydus Wellness Ltd.

27 Aug 2024

2030.70

1.80%

Focused strategies to drive double-digit growth

Buy: Zydus Wellness Ltd.

Target

Sharekhan

We maintain a Buy on Zydus Wellness Limited (ZWL) with an unchanged PT of Rs. 3,000. Stock has run up by 32% since our upgrade to Buy on May 14, 2024.

Zydus Wellness Ltd. has gained 20.86% in the last 3 Months

Zydus Wellness Ltd.

03 Aug 2024

2030.70

1.80%

Zydus Wellness (HOLD): 1QFY25 result review: Risk from La Nina

Hold: Zydus Wellness Ltd.

Target

BOB Capital Markets Ltd.

Sales (+20%) were 7% higher on heatwave but EBITDA was in line with Bloomberg consensus. We forecast +13% sales growth in FY25

Zydus Wellness Ltd. has gained 20.86% in the last 3 Months

Zydus Wellness Ltd.

13 Feb 2024

2030.70

1.80%

First Light | Amber Enterprises, CPI And IIP, Credit Composition, Hero Motocorp, Thermax, Bandhan Bank, Indraprastha Gas, Zydus Wellness

Hold: Zydus Wellness Ltd.

Target

BOB Capital Markets Ltd.

AMBER: Persistent near-term challenges; cut to SELL. CPI and IIP: Still some pain points on inflation. Credit Composition: Study on personal loans. HMCL: Healthy quarter but positives priced in. TMX: Improving order outlook; maintain HOLD. BANDHAN: Recovery on track. IGL: Legacy UP, new GAs can offset slowdown, reiterate BUY. ZYWL: Seasonally weak quarter

Zydus Wellness Ltd. has an average target of 2054.00 from 3 brokers.

Zydus Wellness Ltd.

07 Nov 2023

2030.70

1.80%

Zydus Wellness (HOLD): Subdued growth in a seasonally weak quarter

Hold: Zydus Wellness Ltd.

Target

BOB Capital Markets Ltd.

Flattish volume growth in Q2 owing to muted performance in glucose and sweetener categories

Zydus Wellness Ltd. has gained 20.86% in the last 3 Months

Zydus Wellness Ltd.

06 Nov 2023

2030.70

1.80%

Zydus Wellness

Buy: Zydus Wellness Ltd.

Target

Sharekhan

Zydus Wellness Ltd. has an average target of 2054.00 from 3 brokers.

Zydus Wellness Ltd.

03 Aug 2023

2030.70

1.80%

Decent underlying growth though margin remains under pressure

Buy: Zydus Wellness Ltd.

Target

ICICI Securities Limited

Zydus witnessed a decent performance with double-digit revenue growth (~5% volume growth), excluding the impact of unseasonal rains (~1% YoY reported revenue growth) on Glucon D brand which has higher salience in Q1. Nycil, Nutralite and Everyuth exhibited a good performance, while Complan witnessed good consumer offtakes.

Zydus Wellness Ltd. average weekly volume is high.

Is Zydus Wellness Ltd. worth buying?

136 Votes:

Buy 79.41%

Sell 12.5%

Hold 8.09%

RESEARCH REPORTS

Results Update SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf